Global Acute Lymphocytic/Lymphoblastic leukemia Market 2015-2019
Global Acute Lymphocytic Leukemia Market 2015-2019
Covering: An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of the top companies operating in the market, including Amgen, Bristol-Myers Squibb, and Novartis.Market landscape of acute lymphocytic leukemia
Acute lymphocytic leukemia or acute lymphoblastic leukemia, is a malignancy of the blood cells that affects the lymphoblasts or leukemic blasts, which witnesses an uncontrolled cell division. The main symptoms a patient exhibits are weakness, tiredness, dizziness, fever, shortness of breath, frequent infections, bruising, and bleeding.
Currently, the disease cannot be cured completely but the risk can be reduced by administering medication.
Technavio’s market research analysts expect the global acute lymphocytic leukemia market to grow at a steady rate and post a CAGR of over 4% during the forecast period. One of the major factors contributing to the growth of the market is the provision for orphan drugs. For instance, in the US, orphan designation for a drug means incentives like tax credits for qualified clinical testing, exemption from prescription drug user fees unless indicated for additional non-orphan indications, and market exclusivity for seven years.
Segmentation of the acute lymphocytic leukemia market by route of administration
Technavio Announces the Publication of its Research Report – Global Acute Lymphocytic Leukemia Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Acute Lymphocytic Leukemia Market: Amgen, Bristol-Myers Squibb and Novartis
Other Prominent Vendors in the market are: Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sigma-Tau Pharmaceuticals.
Commenting on the report, an analyst from Technavio’s team said: “The rise in awareness programs to treat acute lymphocytic leukemia patients is one such trend. It increases the treatment-seeking rate among patients, which results in an increase in overall consumption of medicines.”
According to the report, the global acute lymphocytic leukemia therapeutics market is driven by several factors. The presence of high unmet needs for appropriate drugs is one of the major factors propelling the growth of the market. Current treatment options cannot cure the disease completely, hence the demand remains high. Therefore, drugs that can cause disease remission in patients are expected to drive the growth of the market.
Further, the report states that the high cost of treatment is one of the major challenges hindering the growth of the market.
Amgen, Bristol-Myers Squibb, Novartis, Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sigma-Tau Pharmaceuticals.